Literature DB >> 923628

Serum zinc and serum copper and indices of drug metabolism in alcoholics.

T R Hartoma, E A Sotaniemi, O Pelkonen, J Ahlqvist.   

Abstract

Serum zinc and copper levels were studied in relation to in vitro and in vivo drug metabolism in 25 alcoholics, in whom various diseases of the liver had been diagnosed by histology. Serum zinc was elevated in alcoholics with normal or fatty liver and was low in those with alcoholic hepatitis or cirrhosis. There was a significant positive correlation between serum zinc and cytochrome P-450 content of liver biopsies. The relationship between zinc and antipyrine half-life was significant and non-linear. Serum copper level was elevated in all the alcoholics and no significant relationship could be found between copper and drug metabolism in alcoholics. The findings suggest parallelism between changes in serum zinc and indices of drug metabolism in alcoholics.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 923628     DOI: 10.1007/bf00645136

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  24 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Liver mast cell counts during development of cirrhosis of the liver in rats on a low protein, high fat diet.

Authors:  J AHLQVIST
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1960

3.  Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypognadism.

Authors:  A S PRASAD; A MIALE; Z FARID; H H SANDSTEAD; A R SCHULERT
Journal:  J Lab Clin Med       Date:  1963-04

4.  Contrasting effects of thyroxin on zoxazolamine and hexobarbital metabolism.

Authors:  A H CONNEY; L GARREN
Journal:  Biochem Pharmacol       Date:  1961-06       Impact factor: 5.858

5.  [Research on pathophysiology of zinc metabolism].

Authors:  H P WOLFF
Journal:  Klin Wochenschr       Date:  1956-04-15

6.  Transverse mounting of ribbons on groups of slides for comparing different stains in adjacent sections.

Authors:  J Ahlqvist
Journal:  Stain Technol       Date:  1970-01

7.  Drug metabolism and androgen control therapy in prostatic cancer.

Authors:  E A Sotaniemi; M J Kontturi; T K Larmi
Journal:  Clin Pharmacol Ther       Date:  1973 May-Jun       Impact factor: 6.875

8.  Measurements of plasma zinc. I. In health and disease.

Authors:  I J Davies; M Musa; T L Dormandy
Journal:  J Clin Pathol       Date:  1968-05       Impact factor: 3.411

9.  Effect of excess and deficient copper intake on rat liver microsomal enzyme activity.

Authors:  A E Moffitt; S D Murphy
Journal:  Biochem Pharmacol       Date:  1973-06-15       Impact factor: 5.858

10.  Determinants of serum antipyrine half-lives in patients with liver disease.

Authors:  R A Branch; C M Herbert; A E Read
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

View more
  7 in total

1.  Lack of effect of zinc supplementation on antipyrine clearance in alcoholic liver disease.

Authors:  K Grønbaek; H Friis; M Feldman; J Sonne; P B Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 2.  Zinc deficiency as a mediator of toxic effects of alcohol abuse.

Authors:  Anatoly V Skalny; Margarita G Skalnaya; Andrei R Grabeklis; Anastasia A Skalnaya; Alexey A Tinkov
Journal:  Eur J Nutr       Date:  2017-11-24       Impact factor: 5.614

Review 3.  Drug metabolism and pharmacokinetics in malutrition.

Authors:  K Krishnaswamy
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

4.  Preventing Gut Leakiness and Endotoxemia Contributes to the Protective Effect of Zinc on Alcohol-Induced Steatohepatitis in Rats.

Authors:  Wei Zhong; Qiong Li; Qian Sun; Wenliang Zhang; Jiayang Zhang; Xinguo Sun; Xinmin Yin; Xiang Zhang; Zhanxiang Zhou
Journal:  J Nutr       Date:  2015-10-14       Impact factor: 4.798

5.  Dysregulation of hepatic zinc transporters in a mouse model of alcoholic liver disease.

Authors:  Qian Sun; Qiong Li; Wei Zhong; Jiayang Zhang; Xiuhua Sun; Xiaobing Tan; Xinmin Yin; Xinguo Sun; Xiang Zhang; Zhanxiang Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-06-12       Impact factor: 4.052

6.  Effect of zinc supplementation on oxidative drug metabolism in patients with hepatic cirrhosis.

Authors:  M G Barry; P Macmathuna; K Younger; P W Keeling; J Feely
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

7.  Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.

Authors:  A R Boobis; M J Brodie; G C Kahn; D R Fletcher; J H Saunders; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.